
export const autonomicNervousSystemData = {
  name: "Autonomic Nervous System",
  subtopics: {
    essay: {
      name: "Essay",
      questions: [
        "Beta-Blockers ******* (Feb 23;Aug 16;Feb 12;Feb 07;Aug 04;Mar 02;Oct 00) (Pg.No: 157)\nDiscuss:\n- Classification, Pharmacological Effects, Uses, Adverse Effects\n- Drug receptor, Enumerate Beta Blockers, Adverse effects and Contraindications of Non Cardio Selective Beta Blockers\n- Mechanism of action of Proponalol, Pharmacological Action of Proponalol, Therapeutic uses of Proponalol\n- Therapeutic uses, Advantages of cardio Selective Beta Blockers\n- Role of Beta Blockers in Thyrotoxicosis",
        "Adrenaline ***** (Feb 13;Feb 11;Feb 09;Aug 05;Feb 05) (Pg.No: 136)\nDiscuss:\n- Classification of Sympathomimetics, Cardiovascular Action, Therapeutic Uses, Adverse Effects\n- Mechanism of Action, Contraindications",
        "Atropine ** (Aug 09;Aug 07) (Pg.No: 124)\nExplain:\n- Classification of Anti-Cholinergic drugs, Therapeutic Action, Adverse Effects, Contraindications, Managements of Atropine Poisoning\n- Atropine Derivatives and Their Uses",
        "Anti-Cholinersterases (Aug 13;Aug 11) (Pg.No: 116)\nDiscuss:\n- Mechanism of Action, Indication of Reversible Anti-Cholinersterases, Management of Acute Organophosphorus Poisoning",
        "Muscarinic Receptor Blockers (Oct 00) (Pg.No: 124)\nExplain:\n- Natural and Synthetic drugs, Action on Eye and Smooth Muscles with Indications, Systemic Adverse Effects",
        "Organo Phosphorus Compound poisoning (Feb 21) (Pg.No: 122)\nDiscuss:\n- Antidote, Receptor antagonism with suitable diagrams, Cholinergic crisis in Myasthenia Gravis"
      ]
    },
    "short-note": {
      name: "Short Note",
      questions: [
        "Beta-Blockers ********** (Aug 22;Sep 21;Feb 18;Aug 15;Aug 14;Aug 12;Aug 09;Feb 09;Aug 08;Mar 02;Jan 93) (Pg.No: 160)\n- Therapeutic uses, Contraindications\n- Indications, Contraindications, Extra-Cardiac Uses\n- Adverse Effects",
        "Anti-Glaucoma Drugs ***** (Aug 18;Aug 16;Aug 13;Feb 11;Feb 09) (Pg.No: 153)",
        "Management of Organo Phosphorus Poisoning ***** (Feb 23;Dec 19;Feb 17;Feb 15;Aug 10;Aug 08) (Pg.No: 122)\n- Cholinesterase Reactivators",
        "Alpha Adrenergic Blockers **** (Aug 18;Aug 16;Feb 12;Aug 10) (Pg.No: 153)\n- Therapeutic Uses",
        "Drugs for Glaucoma **** (Feb 10;Feb 05;Oct 02;Oct 96) (Pg.No: 165)",
        "Timolol *** (Feb 18;Aug 09;Dec 90) (Pg.No: 167)\n- Rationale for use in the treatment of Glaucoma",
        "Atropine ** (Jul 23;Feb 14) (Pg.No: 124)\n- Pharmacological action, Uses, Substitutes",
        "Dopamine in Cardiogenic Shock ** (Feb 10;Aug 09) (Pg.No: 146)",
        "Drugs used in Open Angle Glaucoma ** (Aug 22;Aug 19) (Pg.No: 166)",
        "Therapeutic uses of Adrenergic Drugs ** (Mar 22;Feb 14) (Pg.No: 150)",
        "Adrenaline (Aug 17) (Pg.No: 136)",
        "Beta Stimulants (Nov 95) (Pg.No: 149)",
        "Cholinergic Crisis (Aug 14) (Pg.No: 121)",
        "Clonidine (Aug 12;Aug 04) (Pg.No: 611)\n- Extravascular Uses",
        "Labetalol (Feb 19) (Pg.No: 165)\n- Uses, Adverse Effects",
        "Proponalol (Aug 04) (Pg.No: 157)",
        "Therapeutic Uses of Atropine (Aug 06) (Pg.No: 130)",
        "Treatment for Benign Prostatic Hypertrophy (BPH) (Jul 23) (Pg.No: 157)\n- Preferred drugs, Rational in using them",
        "Treatment of Myasthenia Gravis (Oct 03) (Pg.No: 120)",
        "Uroselective Alpha Adrenergic Blockers (Aug 12) (Pg.No: 156)"
      ]
    }
  }
};
